Speakers
Next on stage
Speaking in the coming weeks
Hear first-hand from the founders, investors and operators leading our next sessions.
Founder and CEO of Gen AI Academy. Sam is one of the San Francisco Bay Area's leading AI instructors, helping business leaders and their teams use AI as a strategic thought partner. He has trained thousands of professionals, with an emphasis on CEOs and executive teams, drawing on more than two decades of experience in business growth and technology adoption, including leadership roles at five venture-backed startups and a senior executive role at Roofstock.
Speaking at
Using AI (specifically Claude) as a Leadership Tool: A Hands-On Working Session
View event →
Darren Murph was named an “oracle of remote work” by CNBC and included in the Forbes Future of Work 50. He led workplace strategy and operations at GitLab, scaling the world's first fully distributed company to IPO, and later founded Page 52 Consulting, advising organizations including Ford, Dropbox and Zillow. He is the author of several books on remote work, including DISTRIBUTED.
Speaking at
Systems and Culture for building a best-in-class Team
View event →
Darren Murph was named an “oracle of remote work” by CNBC and included in the Forbes Future of Work 50. He led workplace strategy and operations at GitLab, scaling the world's first fully distributed company to IPO, and later founded Page 52 Consulting, advising organizations including Ford, Dropbox and Zillow. He is the author of several books on remote work, including DISTRIBUTED.
Speaking at
The Org Brain: Keeping a Multi-Location, Fractional Team Aligned as You Scale
View event →
Head of Roche Venture Fund. Anja returned to lead the fund in 2026, ten years after first joining its investment team. In between she was CEO of Rewind Therapeutics, a remyelination-focused biotech, and before that a partner at BB Pureos Bioventures. She began her career in Roche's neuroscience R&D group and is a former member of the LifeScience ORG CEO community.
Speaking at
Getting Traction with Pharma Partners
View event →
CEO of Sensorion, a French biotechnology company developing treatments for hearing loss, from 2017 to 2026. Nawal led it through nine years of financing cycles, including a €60 million placement anchored by Sanofi in January 2026. Before Sensorion she spent close to two decades in leadership roles at GE, Baxter/Baxalta and Shire. She is a non-executive director of the Lundbeck Foundation and Croda International.
Speaking at
Building a Team Culture That Can Sustain Performance Under Pressure
View event →
Recently on stage
Recent guests
Every session brings in an outside voice, from first-time founders to the people who run the companies they hope to build.
The Scancell and Neuphoria Therapeutics Merger Agreement and Financing
Commercial Skills a Scientific Founder Needs to Master
Buying AI Is Easy. Becoming a Different Company Is the Hard Part
Preparing for your Exit
Building the Investment Case (Part 2 - The Founder Account)
The Hidden Cost of Getting It Wrong in the U.S.: Site Selection, Lease Risk, and Business Value
Crafting an effective CEO / Board Chair Relationship
Building the Investment Case (Part 1 - The Investor Account)
Building a Superteam
Where you sit, What you sign: The Strategic Weight of Site and Lease Decisions
Engineering Creativity: The Mechanism That Drives Breakthroughs
How CEOs keep the board's confidence... or lose it
Evolving the Equity Story (and the Company with it)
Margins of Safety in Company Building
CEO Clinic: Ivana Magovcevic-Liebisch
How to lead when your team lacks a sense of urgency
China: How to evaluate, diligence and execute
China as a Board-level Conversation: How to evaluate, diligence and execute
Speak with us
We’re always looking for founders, investors and operators with hard-won lessons. Tell us what you could bring to a session.
FAQ
About our speakers
Who takes the stage, and how to join them.